FDA demands new warnings for J&J diabetes drug over amputation risk
May 17, 2017Manufacturing and Production, Research and Development, Sales and Marketing J&J, JJ, Johnson & Johnson, diabetes
Johnson & Johnson has found itself in deep water again over the potentially harmful effects of its products. This time …
Sangamo secures FDA’s Fast Track Designation for haemophilia candidate
May 17, 2017Research and Development, Sales and Marketing FDA, Pfizer, Sangamo Therapeutics
Sangamo Therapeutics has announced that the FDA has granted its cDNA gene therapy candidate for haemophilia A Fast Track Designation. …
Common treatment for MS revealed to have potential adverse reactions
May 16, 2017Manufacturing and Production, Research and Development MS, multiple sclerosis
Beta interferons are a common treatment used to manage multiple sclerosis. The treatment works by reducing and preventing the inflammation …
New FDA Commissioner Gottlieb restructures workforce with product-based focus areas
May 16, 2017Manufacturing and Production, Sales and Marketing FDA, Scott Gottlieb
Scott Gottlieb has wasted no time since his appointment to the role of FDA Commissioner last week. As one of …
European Commission targets Aspen over 1,500% price hikes
May 16, 2017Manufacturing and Production, Sales and Marketing European Commission, aspen
The European Commission (EC) has opened its first investigation over drug pricing following alleged hiking by pharma company Aspen, which …
Patient death sparks safety worries in Ionis trial
May 16, 2017Manufacturing and Production, Research and Development Ionis Pharmaceuticals
Ionis Pharmaceuticals announced the results from a Phase 3 trial of its drug to treat patients with familial amyloid polyneuropathy …
Cuba looks to begin trials of new neuroprotective treatment for Alzheimer’s
May 16, 2017Manufacturing and Production, Research and Development Alzheimer's, Cuba, dementia
The health care system in Cuba is widely held up to be a model of innovation; despite severe economic sanctions …
GSK mulls $8 billion healthcare consolidation deal
May 15, 2017Sales and Marketing GSK, Novartis
When GSK and Novartis first agreed their business swap and healthcare joint venture, it was seen as marking a shift …
Brain drain: The experts the UK may lose due to Brexit
May 15, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brexit
The regulatory and drug approval process is destined to change once the UK leaves the EU. The problem is, nobody …
Malaria expected to be eradicated from 15 Indian states by 2020
May 15, 2017Research and Development, Sales and Marketing India, antimalarial drug resistance, malaria
In good news in the fight against antimalarial drug resistance, the Director of the National Vector Borne Disease Control Programme …
India to immunise five million using Pfizer pneumococcal disease vaccine
May 15, 2017Sales and Marketing 13-valent Pneumococcal Conjugate Vaccine, India, PCV 13, Pfizer
An Indian immunisation programme will make use of Pfizer’s 13-valent Pneumococcal Conjugate Vaccine (PCV 13) to treat around 5.15 million, …
Lilly’s migraine drug succeeds in Phase 3 trials
May 15, 2017Research and Development, Sales and Marketing Eli Lilly, migraines
Eli Lilly announced the successful results of three Phase 3 trials examining the benefits of its drug, galcanezumab, in patients …
FDA green-lights Alembic’s cholesterol drug
May 15, 2017Sales and Marketing Alembic, FDA, cholesterol
Alembic Pharmaceuticals has announced that its fenofibric acid delayed-release capsules have been approved by the FDA for reducing high cholesterol …
IFPMA appoints new Assistant Director General
May 12, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing IFPMA
The International Federation of Pharmaceutical Manufacturers and Associations has followed up its appointment of Thomas Cueni as Director General by …
Top Ten most popular articles on Pharmafile.com this week
May 12, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biggest news, biggest stories, pharma news, pharmaceutical news, top ten
It’s been a bad week for several large pharmaceutical companies this week, with some major failures in clinical trials that …
China threatens prison time and death penalty to fight fraudulent trial data
May 12, 2017Medical Communications, Research and Development, Sales and Marketing China
In a drastic move to help solve its notorious problem with fraudulent clinical trial data, China has introduced a policy …
Brazil declares end to Zika virus emergency
May 12, 2017Medical Communications Brazil, Vaccine, Zika, Zika virus
Brazil has declared that the national emergency over the Zika virus threat is over, after there was a 95% drop …
Novartis signs drug access deal with Pakistan government
May 12, 2017Medical Communications, Sales and Marketing Islamabad, Novartis, Pakistan, market access
Pakistan’s Ministry of National Health Services, Regulations and Coordination has signed an agreement with Novartis to improve access to medicines …
European Medicines Group appoints new officers
May 11, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing European Medicine Group
The European Medicines Group has appointed a new Chair and vice-Chair to its membership body of European companies, with UK-based …
Insider Interview: The battle to defeat antimalarial drug resistance
May 11, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insider Interview, Medicines for Malaria Venture, antimalarial drug resistance, malaria
Pharmafocus spoke to Dr Harald Nusser, Head of Novartis Social Business, and David Reddy, CEO of Medicines for Malaria Venture …
Latest content
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
